Startup · Sweden
Ionlace
HQ Stockholm, SwedenFounded 202311-50 employeesUpdated
We are rewriting the timelines of breakthroughs in medicine.
Funding2 rounds
- Equity raised
- Undisclosed
- Latest
- UndisclosedStage undisclosed · Apr 30, 2024
| Announced | Stage | Amount | Valuation | Lead investors | Other investors | Confidence |
|---|---|---|---|---|---|---|
| Apr 30, 2024 | Undisclosed | Undisclosed | — | — | — | Speculative |
| Jan 1, 2024 | Seed | Undisclosed | — | — | — | Reported |
- UndisclosedSpeculativeUndisclosedApr 30, 2024
- SeedUndisclosedJan 1, 2024
Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.
People1
| Person | Role |
|---|---|
| Robin Visvanathar | Co-founder |
Sources5
Profile2
- 1
Ionlace · Supports Organization · description, Organization · name, Organization · website
“We are rewriting the timelines of breakthroughs in medicine.”
- 2
Sixth-Domain · Supports Organization · country, Organization · kind
“{"country": "Sweden", "hq_iso2": "SE", "id": "d0482fc0-3a38-4463-8c95-b57690e8196e"}”
Funding2
- 3
PitchBook · Supports Funding round · amount, Organization · employee range, Organization · founded year, Organization · linkedin url, Organization · x url
“30-Apr-2024”
- 4
LinkedIn · Supports Funding round, Organization · employee range, Organization · founded year, Organization · hq city, Organization · linkedin url, Organization · ownership
“funding round: Seed Round, 2024-01-01”
People1
- 5
forbes.com · Supports Role
“Robin Visvanathar cofounded Ionlace, a digital biology company using AI and synthetic biology to detect currently undetectable proteins in the body that could be used to more easily diagnose disease.”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.